Stefan K. Barta, MD, MS, MRCPCUK
Hematology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West
Make an appointmentCall 215-615-5858
Penn Medicine Provider

About me

  • Director, T-Cell Lymphoma Program
  • Executive Officer, AIDS Malignancy Consortium
  • Associate Professor of Clinical Medicine (Hematology-Oncology)
  • Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Johann Wolfgang Goethe University
  • Residency: Whipps Cross University Hospital
  • Residency: Burnley General Teaching Hospital
  • Residency: The Whittington Hospital
  • Residency: The St. Bartholomew's and The Royal London
  • Residency: Mount Sinai Morningside
  • Fellowship: The St. Bartholomew's and The Royal London
  • Fellowship: Montefiore Medical Center

What my patients think about me

Average Rating

688 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
he's the best!
November 2025
very professional and caring
November 2025
great experience
October 2025
he's a great doctor

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Barta is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma , Blood Neoplasia, 2(3): 2025

Omar Elghawy, Nishwant Swami, Zachary A. Hing & Stefan K. Barta Advances in T-cell lymphomas and risk factors for CNS involvement , Leukemia & Lymphoma , 66(9): 2025,1583-1602

Omar Elghawy, Julia Wang, Olivia J. Leung, Nishwant Swami, Veronica Carvajal, Guang Yang, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter, Adam Bagg, Stefan K. Barta Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience , Clinical Lymphoma Myeloma and Leukemia, 25(7): 2025,505-511

Nicole J. Altomare, Megan M. Herr, Nisha M. Nair, Deborah M. Stephens, Jonathon B. Cohen, Narendranath Epperla, Matthew Cortese, Rahul Bhansali, Tamara K. Moyo, Vaishalee Kenkre, Thomas Ollila, Brian Hess, Lindsey Fitzgerald, Geoffrey Shouse, James A. Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Adam Lin, Shuo Ma, Jane N. Winter, Alexey Danilov, Stefan K. Barta, Leo I. Gordon, Jason Romancik, Natalie S. Grover and Reem Karmali Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART , Cancers, 17(14): 2025,2358

Danilov AV, Sauter C, Phillips T, Coombs CC, Ip A, Wang Y, Rhodes J, Leslie L, Barrientos J, Saeed H, Strati P, Barta SK, Shadman M. Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference , Clinical Lymphoma Myeloma and Leukemia, 25(6): 2025,e366-e373

Jordan Carter, Jonathan M von Reusner, Mark A Sellmyer, Adam Bagg, Stefan K Barta Common Lymphoma in an Uncommon Location , American Journal of Hematology, 100(8): 2025,1437-1439

Jakub Svoboda, M.D., Daniel J. Landsburg, M.D., James Gerson, M.D., Sunita D. Nasta, M.D., Stefan K. Barta, M.D., Elise A. Chong, M.D., Michael Cook, M.D., Noelle V. Frey, M.D., Joanne Shea, R.N., Amanda Cervini, B.S.N., Amy Marshall, M.P.H., Megan Four, B.S., Megan M. Davis, Ph.D., Julie K. Jadlowsky, Ph.D., Anne Chew, Ph.D., Edward Pequignot, M.S., Vanessa Gonzalez, M.B.A., Julia Han Noll, M.S., Luca Paruzzo, M.D., Juliana Rojas-Levine, B.S., Gabriela Plesa, M.D., Ph.D., John Scholler, M.S., Donald L. Siegel, M.D., Ph.D., Bruce L. Levine, Ph.D., David L. Porter, M.D., Saba Ghassemi, Ph.D., Marco Ruella, M.D., Andrew Rech, M.D., Ph.D., Rachel M. Leskowitz, Ph.D., Joseph A. Fraietta, Ph.D., Wei-Ting Hwang, Ph.D., Elizabeth Hexner, M.D., Stephen J. Schuster, M.D., and Carl H. June, M.D. Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure , The New England Journal of Medicine, 392(18): 2025,1824-1835

Narendranath Epperla, Geoffrey Shouse, Natalie S. Grover, Pallawi Torka, Kaitlin Annunzio, Marcus Watkins, Andrea Anampa-Guzmán, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett & Adam J. Olszewski Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study , Experimental Hematology & Oncology , 14(73): 2025,73

Maillie L, Nasta SD, Svoboda J, Barta SK, Chong EA, Garfall AL, Gill SI, Porter DL, Schuster SJ, Catania C, Frey NV, Landsburg DJ. Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy , Transplant and Cell Therapy, 31(4): 2025,228-235

Dave NK, Carvajal V, Watts AC, Carter JS, Cook M, Thomas C, Tsai DE, Schuster SJ, Gerson JN, Barta SK, Svoboda J, Chong EA, Hwang WT, Landsburg DJ, Nasta SD. Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma , Blood Neoplasia, 2: 2025,100102